Business
Ventripoint Announces Sponsorship for the 54th Annual Meeting of the Association of European Paediatric and Congenital Cardiology
(TheNewswire) Ventripoint Also Provides a Financial Update Toronto, O...
About this update from Ventripoint Diagnostics Ltd.
[{"type":"text","content":"Ventripoint Announces Sponsorship for the 54th Annual Meeting of the Association of European Paediatric and Congenital Cardiology\n \n \n (TheNewswire)\n \n \n \n \n \n \n \n \n Ventripoint Also Provides a Financial Update\n \n \n \n \n Toronto, Ontario – TheNewswire –\nMay 21, 2021\n \n \n - Ventripoint Diagnostics Ltd.\n(\"\n \n \n Ventripoint\n \n \n \" or the \"\n \n \n Company\n \n \n \"), (TSXV:VPT\n \n \n )\n \n \n ;\n \n \n (\n \n \n OTC:VPTDF) is pleased to announce that they will be a Bronze\nlevel sponsor for the 54\n \n \n th\n \n \n Annual Meeting of the Association of\n European Paediatric and Congenital Cardiology (AEPC) to be held\ndigitally on May 25\n \n \n th\n \n \n - 27\n \n \n th,\n \n \n 2021.\n \n \n \n \n The AEPC was founded in Lyon in 1963 and has grown into\na network of specialists in cardiology and related fields. The AEPC\nmission is to promote the knowledge and learning in the field of\ncardiac disease in children.  The current overall membership of the\nAssociation includes 1500 paediatric cardiologists and other\nspecialists.\n \n \n \n \n The event will feature digital platforms with\nplenaries, parallel sessions, digital posters, and industry\nexhibitions. There are an expected 1000 participants, who will include\ninternational physicians, nurses, and technicians in the field of\nPaediatric and Congenital Cardiology.\n \n \n \n \n “The AEPC Annual Meeting is an excellent opportunity\nto inform paediatric cardiologists, who focus on the right side of the\nheart, of the unique ability of the VMS+3.0 to provide accurate and\nreliable volumetric measurements of heart function,” stated Dr.\nGeorge Adams, Executive-Chairman of Ventripoint.\n \n \n \n \n Some highlights of the digital conference will include\nsessions on topics such as timing of pulmonary valve replacements,\noptimal treatment in atrial septum defect in pediatric patients, value\nof ultrasound in congenital heart disease, and much more.\n \n \n \n \n The AEPC 2021 will be showcasing Ventripoint’s\nsupport by having a digital booth on the AEPC digital platform.\n \n \n \n \n Ventripoint is dedicated to the continuous development\nof medical technology that provides value to clinicians in the\nassessment and diagnosis of cardiovascular disease.\n \n \n \n \n In other news, the Company is pro...